Date | Title | Description | Source |
13.03.2023 | 6 questions for SMEs and start-ups looking to become more su... | You can find the original interview (NL) in Trends magazine here.
Sustainability is the corporate s... | heranpartn... |
16.11.2022 | Press release Biocartis Group NV: Biocartis launches a right... | - | globenewsw... |
26.08.2022 | Global Liquid Biopsy Products Market Developing Sector Trend... | Liquid Biopsy Products Market
Liquid Biopsy Products Market Regional Standpoint: North America, Eur... | einpresswi... |
10.01.2022 | Press release Biocartis Group NV: BIOCARTIS MEETS 2021 KEY O... | PRESS RELEASE: REGULATED INFORMATION
10 January 2022, 07:00 CET
BIOCARTIS MEETS 2021 KEY OBJECTIVES... | marketscre... |
10.01.2022 | BIOCARTIS : MEETS 2021 KEY OBJECTIVES | PRESS RELEASE
REGULATED INFORMATION
10 January 2022, 07:00 CET
BIOCARTIS MEETS 2021 KEY OBJECTIVE... | marketscre... |
10.11.2021 | Press release Biocartis Group NV: Biocartis Q3 2021 Business... | PRESS RELEASE: REGULATED INFORMATION
10 November 2021, 07:00 CET
BIOCARTIS Q3 2021 BUSINESS UPDATE
... | marketscre... |
02.11.2021 | Intervest realises fourth turnkey project for tenant Biocart... | Biocartis, located in the Intercity Business Park Mechelen, expands its existing office of 717m² wit... | marketscre... |
12.10.2021 | Biocartis : Disclosure of a transparency notification | PRESS RELEASE
REGULATED INFORMATION
12 October 2021, 07:00 CEST
Disclosure of a transparency noti... | marketscre... |
23.09.2021 | Biocartis : Announces Restart of its High-Throughput Cartrid... | PRESS RELEASE
23 September 2021, 07:00 CEST
Biocartis Announces Restart of its High-Throughput
Ca... | marketscre... |
13.09.2021 | Biocartis : Disclosure of a transparency notification | PRESS RELEASE
REGULATED INFORMATION
13 September 2021, 17:40 CEST
Disclosure of a transparency no... | marketscre... |
02.09.2021 | Biocartis : Launches Idylla™ SARS-CoV-2/Flu/RSV Panel | PRESS RELEASE
2 September 2021, 07:00 CEST
Biocartis Launches Idylla™ SARS-CoV-2/Flu/RSV Panel
Me... | marketscre... |
02.09.2021 | Biocartis : announces H1 2021 results | PRESS RELEASE
REGULATED INFORMATION
2 September 2021, 07:01 CEST
BIOCARTIS ANNOUNCES H1 2021 RESU... | marketscre... |
30.08.2021 | Biocartis : Disclosure of a transparency notification | PRESS RELEASE
REGULATED INFORMATION
30 August 2021, 07:00 CEST
Disclosure of a transparency notif... | marketscre... |
26.08.2021 | BIOCARTIS : ANNOUNCES 2021 HALF-YEAR RESULTS ON 2 SEPTEMBER ... | PRESS RELEASE
REGULATED INFORMATION
26 August 2021, 07:00 CEST
BIOCARTIS ANNOUNCES 2021 HALF-YEAR... | marketscre... |
02.08.2021 | Biocartis : Update on Fire Incident at Biocartis Warehouse | PRESS RELEASE
2 August 2021, 07:00 CET
Update on Fire Incident at Biocartis Warehouse
Mechelen, B... | marketscre... |
31.07.2021 | Biocartis : Fire Incident at Biocartis Warehouse in Mechelen... | PRESS RELEASE
31 July 2021, 18:00 CET
Fire Incident at Biocartis Warehouse in Mechelen, Belgium
M... | marketscre... |
04.06.2021 | BIOCARTIS GROUP NV
Biocartis : Results of the Extraordinary... | PRESS RELEASE
REGULATED INFORMATION
4 June 2021, 17:40 CEST
Results of the Extraordinary Sharehol... | marketscre... |
14.05.2021 | BIOCARTIS GROUP NV
Biocartis : Results of the Shareholders'... | PRESS RELEASE
REGULATED INFORMATION
14 May 2021, 17:40 CEST
Results of the Shareholders' Meetings... | marketscre... |
11.05.2021 | BIOCARTIS GROUP NV
Press release Biocartis Group NV: Biocar... | PRESS RELEASE: 11 May 2021, 07:00 CEST
Biocartis Receives EUR 1.4m Grant to Support Development of ... | marketscre... |
11.05.2021 | BIOCARTIS GROUP NV
Biocartis : Receives EUR 1.4m Grant to S... | PRESS RELEASE
11 May 2021, 07:00 CEST
Biocartis Receives EUR 1.4m Grant to Support Development of
... | marketscre... |
04.05.2021 | BIOCARTIS GROUP NV
Biocartis : Announces New Collaboration ... | PRESS RELEASE
4 May 2021, 07:00 CEST
Biocartis Announces New Collaboration with AstraZeneca to Exp... | marketscre... |
22.04.2021 | BIOCARTIS GROUP NV
BIOCARTIS : Q1 2021 BUSINESS UPDATE | PRESS RELEASE
REGULATED INFORMATION
22 April 2021, 07:01 CEST
BIOCARTIS Q1 2021 BUSINESS UPDATE
... | marketscre... |
20.04.2021 | BIOCARTIS GROUP NV
Biocartis : Announces US FDA 510(k) subm... | PRESS RELEASE
20 April 2021, 07:00 CEST
Biocartis Announces US FDA 510(k) submission of its Idylla... | marketscre... |
13.04.2021 | BIOCARTIS GROUP NV
Biocartis : Invitation to the Annual and... | PRESS RELEASE
REGULATED INFORMATION
13 April 2021, 07:00 CEST
Invitation to the Annual and
Extra... | marketscre... |
01.04.2021 | BIOCARTIS GROUP NV
Biocartis : Announces Publication of 202... | PRESS RELEASE
REGULATED INFORMATION
1 April 2021, 07:00 CEST
Biocartis Announces Publication of 2... | marketscre... |
01.09.2020 | Biocartis expands collaboration with LifeArc | Mechelen, Belgium, and London, UK, 1 September 2020 – Biocartis Group NV (the ‘Company’ or ‘Biocarti... | lifearc.or... |
27.04.2015 | Biocartis raises EUR100 million in successful public offerin... |
The final offer price for the Offering has been set at EUR 11.50, giving the Company an initial ma... | startuptic... |
12.09.2014 | Biocartis launches its flagship diagnostics platform Idylla |
Biocartis, an innovative molecular diagnostics company, announced today that it has officially lau... | startuptic... |
05.09.2014 | Biocartis Raises €64.5M | Biocartis, a Mechelen, Belgium- and Lausanne, Switzerland-based provider of a molecular diagnostics ... | finsmes.co... |
04.09.2014 | Biocartis Raises EUR 64.5 Million plus EUR 15 Million for a ... | - | jnjinnovat... |
04.09.2014 | Biocartis raises EUR 64.5 million plus EUR 15 million for a ... |
The capital round for Biocartis itself is subscribed by Johnson & Johnson Development Corporat... | startuptic... |
06.11.2013 | Biocartis Completes €30M Series E Equity Funding | Biocartis, a Lausanne, Switzerland- and Mechelen, Belgium-based molecular diagnostics company develo... | finsmes.co... |
05.11.2013 | Biocartis raises EUR 30 million and prepares for market entr... |
This series E round was entirely subscribed by the existing shareholders such as RMM (Rudi Mariën)... | startuptic... |
24.10.2013 | Market launch of Biocartis‘ diagnostic platform is on the ho... |
Idylla is Biocartis’ commercial brand name for the fully integrated molecular diagnostic platform,... | startuptic... |
18.10.2013 | Biocartis and Hospital del Mar develop diagnostic colon canc... |
Biocartis is active in molecular diagnostics and develops innovative diagnostic platforms, which a... | startuptic... |
18.03.2013 | Biocartis strengthens management team with Chief Medical Off... | Stefan Scherer joins Biocartis most recently from Hoffmann-La Roche/Genentech, where he held several... | startuptic... |
25.02.2013 | Biocartis receives 1.9 M subsidy for the development of new... |
Biocartis is a molecular diagnostics company that develops clinically relevant tests and innovativ... | startuptic... |
01.02.2013 | Investment Record for EPFL Spin-offs |
The EPFL spin-offs generated considerable cash flow over the last year: 98 million francs. The ten... | startuptic... |
14.12.2012 | Biocartis completes CHF42million Series D Fund Raising |
Biocartis, a molecular diagnostics company developing and commercializing innovative, high quality... | startuptic... |
12.12.2012 | Biocartis Completes €34,5 Million ($44,5 Million) Series D F... | - | jnjinnovat... |
12.12.2012 | Biocartis Completes €34,5M Series D Equity Funding | Biocartis, a Lausanne, Switzerland-based molecular diagnostics company developing and commercializin... | finsmes.co... |
22.06.2012 | Debiopharm, Immunexpress and Biocartis Announce Collaboratio... |
Normal 0 21 false false false DE-CH X-NONE X-NONE Debiopharm will fund the validation and U.S. Foo... | startuptic... |
05.06.2012 | Biocartis collaborates with Philips and Wellcome Trust |
Normal 0 21 false false false DE-CH X-NONE X-NONE Biocartis, Philips and Wellcome Trust will devel... | startuptic... |
17.11.2011 | Biocartis Completes €71M Series C Equity Funding | Biocartis, a Lausanne, Switzerland-based company developing and commercializing compact molecular di... | finsmes.co... |
17.11.2011 | Biocartis completes EUR 71 million financing round |
Normal 0 21 false false false DE X-NONE X-NONE MicrosoftInternetExplorer4 Biocartis, a company dev... | startuptic... |
17.11.2011 | Biocartis Completes EUR 71 Million Series C |
Company developing and commercializing compact molecular diagnostic (MDx) systems raised funds fro... | vcnewsdail... |
08.04.2010 | Biocartis Closes €30M Series B Financing | Biocartis SA, a Lausanne, Switzerland-based biotech company active in the field of personalized medi... | finsmes.co... |
15.10.2009 | Swiss Biocartis Raises €10M in Series A Financing Round | Biocartis SA closed its €10m ($14.9m) Series A equity financing round led by Amsterdam-based Aescap ... | finsmes.co... |